234 related articles for article (PubMed ID: 10571411)
21. Secretion of matrix metalloproteinase-2 (72 kD gelatinase/type IV collagenase = gelatinase A) by malignant human glioma cell lines: implications for the growth and cellular invasion of the extracellular matrix.
Nakagawa T; Kubota T; Kabuto M; Fujimoto N; Okada Y
J Neurooncol; 1996 Apr; 28(1):13-24. PubMed ID: 8740587
[TBL] [Abstract][Full Text] [Related]
22. An inverse correlation between expression of NCAM-A and the matrix-metalloproteinases gelatinase-A and gelatinase-B in human glioma cells in vitro.
Maidment SL; Rucklidge GJ; Rooprai HK; Pilkington GJ
Cancer Lett; 1997 Jun; 116(1):71-7. PubMed ID: 9177460
[TBL] [Abstract][Full Text] [Related]
23. Expression of matrix metalloproteinases in human glioma cell lines in the presence of IL-10.
Wagner S; Stegen C; Bouterfa H; Huettner C; Kerkau S; Roggendorf W; Roosen K; Tonn JC
J Neurooncol; 1998 Nov; 40(2):113-22. PubMed ID: 9892093
[TBL] [Abstract][Full Text] [Related]
24. Tenascin-C stimulates glioma cell invasion through matrix metalloproteinase-12.
Sarkar S; Nuttall RK; Liu S; Edwards DR; Yong VW
Cancer Res; 2006 Dec; 66(24):11771-80. PubMed ID: 17178873
[TBL] [Abstract][Full Text] [Related]
25. Regulation of matrix metalloproteinase-2 (MMP-2) by hepatocyte growth factor/scatter factor (HGF/SF) in human glioma cells: HGF/SF enhances MMP-2 expression and activation accompanying up-regulation of membrane type-1 MMP.
Hamasuna R; Kataoka H; Moriyama T; Itoh H; Seiki M; Koono M
Int J Cancer; 1999 Jul; 82(2):274-81. PubMed ID: 10389763
[TBL] [Abstract][Full Text] [Related]
26. Expression of emmprin (CD147), a cell surface inducer of matrix metalloproteinases, in normal human brain and gliomas.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Int J Cancer; 2000 Oct; 88(1):21-7. PubMed ID: 10962435
[TBL] [Abstract][Full Text] [Related]
27. Inhibition of cell invasion by indomethacin on glioma cell lines: in vitro study.
Wang M; Yoshida D; Liu S; Teramoto A
J Neurooncol; 2005 Mar; 72(1):1-9. PubMed ID: 15803368
[TBL] [Abstract][Full Text] [Related]
28. Matrix metalloproteinases in cancer.
Itoh Y; Nagase H
Essays Biochem; 2002; 38():21-36. PubMed ID: 12463159
[TBL] [Abstract][Full Text] [Related]
29. Downregulation of the RECK-tumor and metastasis suppressor gene in glioma invasiveness.
Correa TC; Brohem CA; Winnischofer SM; da Silva Cardeal LB; Sasahara RM; Taboga SR; Sogayar MC; Maria-Engler SS
J Cell Biochem; 2006 Sep; 99(1):156-67. PubMed ID: 16791855
[TBL] [Abstract][Full Text] [Related]
30. Differential expression of membrane-type matrix metalloproteinase and its correlation with gelatinase A activation in human malignant brain tumors in vivo and in vitro.
Yamamoto M; Mohanam S; Sawaya R; Fuller GN; Seiki M; Sato H; Gokaslan ZL; Liotta LA; Nicolson GL; Rao JS
Cancer Res; 1996 Jan; 56(2):384-92. PubMed ID: 8542596
[TBL] [Abstract][Full Text] [Related]
31. The value and correlation between PRL-3 expression and matrix metalloproteinase activity and expression in human gliomas.
Kong L; Li Q; Wang L; Liu Z; Sun T
Neuropathology; 2007 Dec; 27(6):516-21. PubMed ID: 18021371
[TBL] [Abstract][Full Text] [Related]
32. Interactions of glioma cells and extracellular matrix.
Paulus W; Tonn JC
J Neurooncol; 1995; 24(1):87-91. PubMed ID: 8523081
[TBL] [Abstract][Full Text] [Related]
33. Roles of membrane type 1 matrix metalloproteinase and tissue inhibitor of metalloproteinases 2 in invasion and dissemination of human malignant glioma.
Nakada M; Kita D; Futami K; Yamashita J; Fujimoto N; Sato H; Okada Y
J Neurosurg; 2001 Mar; 94(3):464-73. PubMed ID: 11235952
[TBL] [Abstract][Full Text] [Related]
34. The other side of MMPs: protective roles in tumor progression.
Martin MD; Matrisian LM
Cancer Metastasis Rev; 2007 Dec; 26(3-4):717-24. PubMed ID: 17717634
[TBL] [Abstract][Full Text] [Related]
35. The expression and activation of matrix metalloproteinase-2 in rat brain after implantation of C6 rat glioma cells.
Kodera T; Nakagawa T; Kubota T; Kabuto M; Sato K; Kobayashi H
J Neurooncol; 2000; 46(2):105-14. PubMed ID: 10894363
[TBL] [Abstract][Full Text] [Related]
36. Expression and localization of 92 kDa type IV collagenase/gelatinase B (MMP-9) in human gliomas.
Rao JS; Yamamoto M; Mohaman S; Gokaslan ZL; Fuller GN; Stetler-Stevenson WG; Rao VH; Liotta LA; Nicolson GL; Sawaya RE
Clin Exp Metastasis; 1996 Jan; 14(1):12-8. PubMed ID: 8521611
[TBL] [Abstract][Full Text] [Related]
37. Effect of synthetic matrix-metalloproteinase inhibitors on invasive capacity and proliferation of human malignant gliomas in vitro.
Tonn JC; Kerkau S; Hanke A; Bouterfa H; Mueller JG; Wagner S; Vince GH; Roosen K
Int J Cancer; 1999 Mar; 80(5):764-72. PubMed ID: 10048980
[TBL] [Abstract][Full Text] [Related]
38. Differential expression and localization of TIMP-1 and TIMP-4 in human gliomas.
Groft LL; Muzik H; Rewcastle NB; Johnston RN; Knäuper V; Lafleur MA; Forsyth PA; Edwards DR
Br J Cancer; 2001 Jul; 85(1):55-63. PubMed ID: 11437402
[TBL] [Abstract][Full Text] [Related]
39. Glioma cell extracellular matrix metalloproteinase inducer (EMMPRIN) (CD147) stimulates production of membrane-type matrix metalloproteinases and activated gelatinase A in co-cultures with brain-derived fibroblasts.
Sameshima T; Nabeshima K; Toole BP; Yokogami K; Okada Y; Goya T; Koono M; Wakisaka S
Cancer Lett; 2000 Sep; 157(2):177-84. PubMed ID: 10936678
[TBL] [Abstract][Full Text] [Related]
40. Localization of gelatinase activities in glioma tissues by film in situ zymography.
Takano S; Tsuboi K; Matsumura A; Sato H; Nose T
Brain Tumor Pathol; 2001; 18(2):145-50. PubMed ID: 11908871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]